In the brain, GLP-1 treatment has a preventive effect on the progression of Alzheimer’s disease pathology in rats (Iwai et al., 2014; Solmaz et al., 2015). The gene discussed is GCG; the disease is early-onset autosomal dominant Alzheimer disease.